Core‐Shell Reactor Partitioning Enzyme and Prodrug by ZIF‐8 for NADPH‐Sensitive In Situ Prodrug Activation
Angewandte Chemie International Edition · 2023
DOI: 10.1002/anie.202314025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2023. Verfasst von Bo Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, 210009, China. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Double First-Class University Plan, Jiangsu Province Key R&D Plan Social Development Project.
Abstract (Originalsprache)
Enzyme‐prodrug therapies have shown unique advantages in efficiency, selectivity, and specificity of in vivo prodrug activation. However, precise spatiotemporal control of both the enzyme and its substrate at the target site, preservation of enzyme activity, and in situ substrate depletion due to low prodrug delivery efficiency continue to be great challenges. Here, we propose a novel core–shell reactor partitioning enzyme and prodrug by ZIF‐8, which integrates an enzyme with its substrate and increases the drug loading capacity (DLC) using a prodrug as the building ligand to form a Zn‐prodrug shell. Cytochrome P450 (CYP450) is immobilized in ZIF‐8, and the antitumor drug dacarbazine (DTIC) is coordinated and deposited in its outer layer with a high DLC of 43.6±0.8 %. With this configuration, a much higher prodrug conversion efficiency of CYP450 (36.5±1.5 %) and lower IC 50 value (26.3±2.6 μg/mL) are measured for B16‐F10 cells with a higher NADPH concentration than those of L02 cells and HUVECs. With the tumor targeting ability of hyaluronic acid, this core–shell enzyme reactor shows a high tumor suppression rate of 96.6±1.9 % and provides a simple and versatile strategy for enabling in vivo biocatalysis to be more efficient, selective, and safer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, 210009, China.
- Department of Biochemistry, School of Life Science and Technology, China Pharmaceutical University, Nanjing, 210009, China.
- State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, China.
- State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, China.
- Key Laboratory of Mesoscopic Chemistry of Ministry of Education, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, China.
ORCID-Profile: Ya Ding
Förderung
- National Natural Science Foundation of China
- Double First-Class University Plan
- Jiangsu Province Key R&D Plan Social Development Project
- Open Project Program of MOE Key Laboratory of Drug Quality Control and Pharmacovigilance
Zitieren
APA
Wang, B., Zhang, S., Shen, Z. T., Hou, T., Zhao, Y. H., Huang, M. S., Li, J., Chen, H., Hu, P. H., Luo, Z. J., Yuan, S., Wang, F. M., Li, W., Shu, C., Xia, X. H., & Ding, Y. (2023). Core‐Shell Reactor Partitioning Enzyme and Prodrug by ZIF‐8 for NADPH‐Sensitive In Situ Prodrug Activation. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202314025
Vancouver
Wang B, Zhang S, Shen ZT, Hou T, Zhao YH, Huang MS, et al. Core‐Shell Reactor Partitioning Enzyme and Prodrug by ZIF‐8 for NADPH‐Sensitive In Situ Prodrug Activation. Angewandte Chemie International Edition. 2023. doi:10.1002/anie.202314025
BibTeX
@article{Wang2023,
author = {Wang, Bo and Zhang, Sheng and Shen, Zi-Tao and Hou, Ting and Zhao, Yi-Han and Huang, Meng-Sheng and Li, Jian and Chen, Huan and Hu, Peng-Hui and Luo, Zi-Jiang and Yuan, Shuai and Wang, Feng-Min and Li, Wei and Shu, Chang and Xia, Xing-Hua and Ding, Ya},
title = {Core‐Shell Reactor Partitioning Enzyme and Prodrug by ZIF‐8 for NADPH‐Sensitive In Situ Prodrug Activation},
journal = {Angewandte Chemie International Edition},
year = {2023},
doi = {10.1002/anie.202314025}
}
EUVIMED